Navidea (NAVB) Appoints Anton Gueth To Board Of Directors

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) announces today the appointment of Mr. Anton Gueth to fill an open position on the Navidea Board of Directors. Mr. Gueth's initial term of service will last until the Company's 2016 Annual Meeting at which time he is expected to stand for re-election. Mr. Gueth brings over 30 years of global finance and operating experience in the pharmaceutical and healthcare industries.